In one retrospective study that reviewed 40 patients who had AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1, 12.5% of the patients were diagnosed with SM or MML when bone marrow biopsies were tested for the KIT D816V mutation [60]. Here, RUNX1 is linked to systemic mastocytosis.